DCT

1:20-cv-00019

Boehringer Ingelheim Pharma Inc v. Mylan Pharma Inc

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

02/05/20

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (07/02/21)

Patent Owner

Operating Company (W)

PACER

Nature of Suit830 Patent

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Period	PO Win Rate
Thomas S. Kleeh	01/24/22 - 08/28/24	50%
John P. Bailey	06/15/20 - 01/24/22	50%

Plaintiff

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Boehringer Ingelheim Intl GmbH	L3 C

No Parties

Attorney

Name	Ratings
Kirkland & Ellis LLP	L5 A
Patrick J. Coyne	L5 A
Neal S. Cohen	L5 A
Peter Kinsella	L5 A
Scott E. Holwick	L5 A
Robert D. Bajefsky	L5 A
Jennifer S. Swan	L5 A
Aaron M. Raphael	L5 A
Hugh S. Balsam	L5 A
Lisa A. Jakob	L5 A
David A. Nelson	L5 A
Steven M. Bauer	L5 A
Schrader BYRD & Companion PLLCLocal	L5 A
Scott J. Popma	L5 A
Angie M. Hankins	L5 A
Carey Douglas Kessler & Ruby PLLCLocal	L5 A
Richard W. Hanes	L5 A
Timothy J. Schutz	L5 A
Marc R. Labgold	L5 A

No Attorneys

Defendant

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A

No Parties

Attorney

No Attorneys